Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000902664-25-001335·Whitehawk Therapeutics, Inc.
Schedule 13D ownership disclosure
Whitehawk Therapeutics, Inc.
Common stock, par value $0.0001 per share · CUSIP: 00032Q104
Event date: 2025-02-28
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- AVORO CAPITAL ADVISORS LLCReported CIK 0001633313
Shares: 9,515,802.00 · Class: 18.0%
- AVORO VENTURES LLCReported CIK 0001879253
Shares: 2,288,950.00 · Class: 4.8%
- BEHZAD AGHAZADEHReported CIK 0001701815
Shares: 11,914,961.00 · Class: 19.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-001335
- Form type
- SCHEDULE 13D/A
- Filer
- Whitehawk Therapeutics, Inc.
- CIK
- CIK 1422142
- Filed
- Mar 04, 2025
- Reporting period
- Feb 28, 2025
- Description
- Schedule 13D beneficial ownership